Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.

Rotstein, C; Cimino, M; Winkey, K; Cesari, C; Fenner, J

Rotstein, C; Cimino, M; Winkey, K; Cesari, C; Fenner, J.

Affiliation

Rotstein C; Roswell Park Memorial Institute, Buffalo, New York 14263.

Am J Med ; 85(1A): 36-43, 1988 Jul 25.

Article in En | MEDLINE | ID: mdl-3041817

Subject(s)

Agranulocytosis/complications; Anti-Bacterial Agents/administration & dosage; Fever/complications; Neutropenia/complications; Tobramycin/administration & dosage; Adolescent; Adult; Aged; Anti-Bacterial Agents/adverse effects; Bacterial Infections/complications; Bacterial Infections/drug therapy; Bacterial Infections/microbiology; Cefoperazone/administration & dosage; Cefoperazone/adverse effects; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Mezlocillin/administration & dosage; Mezlocillin/adverse effects; Middle Aged; Piperacillin/administration & dosage; Piperacillin/adverse effects; Prospective Studies; Random Allocation; Tobramycin/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tobramycin / Agranulocytosis / Fever / Anti-Bacterial Agents / Neutropenia Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Med Year: 1988 Type: Article

Search on Google

XML

PubMed Links